Novanta/NOVT

$158.25

-0.18%
-
1D1W1MYTD1YMAX

About Novanta

Novanta Inc. is a global supplier of core technology solutions to medical and advanced industrial original equipment manufacturers. Its segments include Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures and markets photonics-based solutions, including laser scanning, laser beam delivery, carbon dioxide (CO2) laser, solid state laser, ultrafast laser, and optical light engine products to customers worldwide. The Vision segment designs, manufactures and markets a range of medical grade technologies, including medical insufflators, pumps and related disposables; visualization solutions; wireless technologies, video recorder and video integration technologies. The Precision Motion segment designs, manufactures and markets optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles to customers worldwide.

Ticker

NOVT

Sector

Technology

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Matthijs Glastra

Employees

3,000

Headquarters

Bedford, United States

Novanta Metrics

BasicAdvanced
$5.68B
Market cap
75.50
P/E ratio
$2.10
EPS
1.31
Beta
-
Dividend rate

What the Analysts think about Novanta

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 2 analysts.
3.95% upside
High $167.00
Low $162.00
$158.25
Current price
$164.50
Average price target

Novanta Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
9.57% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$221.5M
-3.44%
Net income
$21.2M
1.92%
Profit margin
9.57%
5.63%

Novanta Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 14.35%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.75
$0.74
$0.80
$0.85
-
Expected
$0.72
$0.64
$0.73
$0.74
$0.63
Surprise
4.17%
15.03%
9.59%
14.35%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Novanta stock

Buy or sell Novanta stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing